November is known around the world as the official month of awareness and prevention of prostate cancer, and the "November Blue" campaign draws attention to the risks associated with the disease and motivation for routine research.
According to the Ministry of Health, prostate cancer ranks second in the ranking of the most common diseases among men, only for skin cancer.
In addition to research and recommended care, maintaining regular sleep can also help fight this type of cancer.
Melatonin, known as a sleep-regulating hormone, has the potential to slow down cancer growth. The substance acts to control the formation of new blood vessels from the already existing vascular system of the tumor, a process called angiogenesis.
According to Renata Federighi, Duoflex Sleep Consultant, melatonin is formed naturally in response to lack of illumination, responsible for notifying the body that is at bedtime. "It is essential that people sleep without the interference of light, so as not to interfere with their production and do not harm their health," he explains.
At night, the cells need to rest completely in order not to lose their performance and suffer from mutations that can cause the appearance of cancer. "A few hours of sleep also weakens the immune system and promotes inflammation, leaving the body more susceptible to cancer" – adds Renata.
Harvard for prostate cancer
A study by Harvard University in the United States found that satisfactory levels of melatonin could reduce the risk of prostate cancer. 928 men were evaluated, those who showed high levels of the hormone, the probability of a disease that turned out to be 75% lower.
The specialist gives advice on the quality of sleep and the correct repair of body functions. "It is important to pay attention to the posture, use a cushion that provides comfort and support for the head, and which aligns the spine, keep the environment cool and are as silent and dark as possible, eat healthy and avoid stimulating activities before sleep" – summarizes the Dream Duoflex consultant.